Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?

Auteurs : Klastersky J, Awada A
Année : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(1)
Pages : 17-23

Febrile neutropenia: a critical review of the initial management.

Auteurs : Klastersky J, Awada A, Paesmans M, Aoun M
Année : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(3)
Pages : 185-94

Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?

Auteurs : Paesmans M, Klastersky J, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Ameye L
Année : 2011
Journal : Support Care Cancer
Volume : 19(7)
Pages : 1001-8